ARCHIVES

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Susan Sieber, Former NCI Communications Chief, Dead.

January 25, 2002

Program Announcement Completes NCI switch To Control Research

April 16, 1982

Overhead Caused By Outreach, Other Federal Programs Threatens Cancer Centers, Durant Contends

November 5, 1976

Illinois Congressman Calls For Full Bypass Budget Appropriation In cancer Prevention – $180 Million

February 22, 1991

R. Lee Clark Clinic Dedication To Honor M.D. Anderson’s “Architect”

November 13, 1987

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989